Open AccessPro-Angiogenic Actions of CMC-Derived Extracellular Vesicles Rely on Selective Packaging of Angiopoietin 1 and 2, but Not FGF-2 and VEGF
Author(s) -
Marcin Wysoczynski,
Asif R. Pathan,
Joseph B. Moore,
Talha Farid,
Jae Kim,
Marjan Nasr,
Yi Kang,
Hong Li,
Roberto Bolli
Publication year - 2019
Publication title -
stem cell reviews
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.247
H-Index - 73
eISSN - 1558-6804
pISSN - 1550-8943
DOI - 10.1007/s12015-019-09891-6
Subject(s) - paracrine signalling , angiogenesis , microbiology and biotechnology , angiopoietin receptor , microvesicles , stromal cell , cell migration , pi3k/akt/mtor pathway , protein kinase b , biology , endothelial stem cell , exosome , chemistry , cancer research , signal transduction , cell , biochemistry , receptor , in vitro , microrna , gene
While the fundamental mechanism by which cardiac cell therapy mitigates ventricular dysfunction in the post ischemic heart remains poorly defined, donor cell paracrine signaling is presumed to be a chief contributor to the afforded benefits. Of the many bioactive molecules secreted by transplanted cells, extracellular vesicles (EVs) and their proteinaceous, nucleic acid, and lipid rich contents, comprise a heterogeneous assortment of prospective cardiotrophic factors-whose involvement in the activation of endogenous cardiac repair mechanism(s), including reducing fibrosis and promoting angiogenesis, have yet to be fully explained. In the current study we aimed to interrogate potential mechanisms by which cardiac mesenchymal stromal cell (CMC)-derived EVs contribute to the CMC pro-angiogenic paracrine signaling capacity in vitro. Vesicular transmission and biological activity of human CMC-derived EVs was evaluated in in vitro assays for human umbilical vein endothelial cell (HUVEC) function, including EV uptake, cell survival, migration, tube formation, and intracellular pathway activation. HUVECs incubated with EVs exhibited augmented cell migration, tube formation, and survival under peroxide exposure; findings which paralleled enhanced activation of the archetypal pro-survival/pro-angiogenic pathways, STAT3 and PI3K-AKT. Cytokine array analyses revealed preferential enrichment of a subset of prototypical angiogenic factors, Ang-1 and Ang-2, in CMC EVs. Interestingly, pharmacologic inhibition of Tie2 in HUVECs, the cognate receptors of angiopoietins, efficiently attenuated CMC-EV-induced HUVEC migration. Further, in additional assays a Tie2 kinase inhibitor exhibited specificity to inhibit Ang-1-, but not Ang-2-, induced HUVEC migration. Overall, these findings suggest that the pro-angiogenic activities of CMC EVs are principally mediated by Ang-1-Tie2 signaling.